When the Food and Drug Administration speaks...

...people should listen.  From the London Daily Mail:

FDA panel votes 16-2 AGAINST recommending to approve Pfizer booster shots to healthy people under 65 because there is not enough evidence they are safe and effective

• • The FDA's advisory committee voted 16-2 to not recommend approval of Covid booster shots of Pfizer's vaccine for healthy people under age 65
  • Members said there was not enough evidence that a third dose was safe and effective for use in all Americans
  • A second vote unanimously approved booster shots for specific groups including those aged 65 and older at high risk due to their jobs
  • Pfizer said data suggested efficacy of two doses declines from 96.2% to 83.7% after six months but that a third dose boosts antibody levels
  • FDA officials have previously expressed doubt about the need for extra doses and say the vaccines are still highly effective against severe disease and death

An independent panel at the U.S. Food and Drug Administration (FDA) has voted unanimously to recommend approval of booster doses for the Pfizer-BioNTech COVID-19 vaccine - but only for specific at-risk groups.

These groups include older adults aged 65 and older and those who are at high risk of developing a severe case of the virus.

It comes after a first vote Vaccines and Related Biological Products Advisory Committee (VRBPAC) was 16-2 against boosters for all healthy Americans.

Members said said there was not enough evidence that a third dose was safe and effective for use in people under age 65.

Not exactly confidence building...